Literature DB >> 21975858

Cerebellar cognitive affective syndrome in Machado Joseph disease: core clinical features.

Pedro Braga-Neto1, José Luiz Pedroso, Helena Alessi, Lívia Almeida Dutra, André Carvalho Felício, Thaís Minett, Patrícia Weisman, Ruth F Santos-Galduroz, Paulo Henrique F Bertolucci, Alberto Alain Gabbai, Orlando Graziani Povoas Barsottini.   

Abstract

The cerebellum is no longer considered a purely motor control device, and convincing evidence has demonstrated its relationship to cognitive and emotional neural circuits. The aims of the present study were to establish the core cognitive features in our patient population and to determine the presence of Cerebellar Cognitive Affective Syndrome (CCAS) in this group. We recruited 38 patients with spinocerebellar ataxia type 3 (SCA3) or Machado–Joseph disease (MJD)-SCA3/MJD and 31 controls. Data on disease status were recorded (disease duration, age, age at onset, ataxia severity, and CAG repeat length). The severity of cerebellar symptoms was measured using the International Cooperative Ataxia Rating Scale and the Scale for the Assessment and Rating of Ataxia. The neuropsychological assessment consisted of the Mini-Mental State Examination, Clock Drawing Test, Wechsler Adult Intelligence Scale, Rey–Osterrieth Complex Figure, Wisconsin Card Sorting Test, Stroop Color–Word Test, Trail-Making Test, Verbal Paired Associates, and verbal fluency tests. All subjects were also submitted to the Hamilton Anxiety Scale and Beck Depression Inventory. After controlling for multiple comparisons, spatial span, picture completion, symbol search, Stroop Color–Word Test, phonemic verbal fluency, and Trail-Making Tests A and B were significantly more impaired in patients with SCA3/MJD than in controls. Executive and visuospatial functions are impaired in patients with SCA3/MJD, consistent with the symptoms reported in the CCAS. We speculate on a possible role in visual cortical processing degeneration and executive dysfunction in our patients as a model to explain their main cognitive deficit.

Entities:  

Mesh:

Year:  2012        PMID: 21975858     DOI: 10.1007/s12311-011-0318-6

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  39 in total

1.  Cognitive repercussions of hereditary cerebellar disorders.

Authors:  Mario Manto; Thomas Lorivel
Journal:  Cortex       Date:  2009-05-18       Impact factor: 4.027

Review 2.  An emerging concept. The cerebellar contribution to higher function.

Authors:  J D Schmahmann
Journal:  Arch Neurol       Date:  1991-11

3.  Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n.

Authors:  L B Jardim; M L Pereira; I Silveira; A Ferro; J Sequeiros; R Giugliani
Journal:  Arch Neurol       Date:  2001-06

4.  Visual motion perception deficits due to cerebellar lesions are paralleled by specific changes in cerebro-cortical activity.

Authors:  Barbara Händel; Peter Thier; Thomas Haarmeier
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

5.  Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6.

Authors:  Ina Klinke; Martina Minnerop; Tanja Schmitz-Hübsch; Marc Hendriks; Thomas Klockgether; Ullrich Wüllner; Christoph Helmstaedter
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

6.  Machado-Joseph disease of Azorean ancestry in Brazil: the Catarina kindred. Neurological, neuroimaging, psychiatric and neuropsychological findings in the largest known family, the "Catarina" kindred.

Authors:  J Radvany; C H Camargo; Z M Costa; N C Fonseca; E D Nascimento
Journal:  Arq Neuropsiquiatr       Date:  1993-03       Impact factor: 1.420

7.  The gene for Machado-Joseph disease maps to human chromosome 14q.

Authors:  Y Takiyama; M Nishizawa; H Tanaka; S Kawashima; H Sakamoto; Y Karube; H Shimazaki; M Soutome; K Endo; S Ohta
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

8.  Executive and emotional dysfunction in Machado-Joseph disease.

Authors:  Tricia M Zawacki; Janet Grace; Joseph H Friedman; Lewis Sudarsky
Journal:  Mov Disord       Date:  2002-09       Impact factor: 10.338

Review 9.  New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease).

Authors:  Udo Rüb; Ewout R Brunt; Thomas Deller
Journal:  Curr Opin Neurol       Date:  2008-04       Impact factor: 5.710

10.  Cognitive deficits in Machado-Joseph disease.

Authors:  P Maruff; P Tyler; T Burt; B Currie; C Burns; J Currie
Journal:  Ann Neurol       Date:  1996-09       Impact factor: 10.422

View more
  25 in total

1.  Cognitive deficits in Machado-Joseph disease correlate with hypoperfusion of visual system areas.

Authors:  Pedro Braga-Neto; Lívia Almeida Dutra; José Luiz Pedroso; André C Felício; Helena Alessi; Ruth F Santos-Galduroz; Paulo Henrique F Bertolucci; Mário Luiz V Castiglioni; Rodrigo Affonseca Bressan; Griselda Esther Jara de Garrido; Orlando Graziani Povoas Barsottini; Andrea Jackowski
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

2.  Personality and Neuropsychological Profiles in Friedreich Ataxia.

Authors:  Sabrina Sayah; Jean-Yves Rotgé; Hélène Francisque; Marcela Gargiulo; Virginie Czernecki; Damian Justo; Khadija Lahlou-Laforet; Valérie Hahn; Massimo Pandolfo; Antoine Pelissolo; Philippe Fossati; Alexandra Durr
Journal:  Cerebellum       Date:  2018-04       Impact factor: 3.847

3.  Cognition in SCA21 reflects developmental and adult onset cerebellar cognitive affective syndrome.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Orlando G P Barsottini; Jeremy D Schmahmann
Journal:  Brain       Date:  2015-01-08       Impact factor: 13.501

4.  Early-onset familial Alzheimer's disease related to presenilin 1 mutation resembling autosomal dominant spinocerebellar ataxia.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Helena Alessi; Paulo Victor Sgobbi de Souza; Paulo Henrique Ferreira Bertolucci; Orlando Graziani Povoas Barsottini
Journal:  J Neurol       Date:  2013-03-13       Impact factor: 4.849

5.  Psychosis in Machado-Joseph Disease: Clinical Correlates, Pathophysiological Discussion, and Functional Brain Imaging. Expanding the Cerebellar Cognitive Affective Syndrome.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Ary Gadelha; Maura Regina Laureano; Cristiano de Souza Noto; Griselda Jara Garrido; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2016-08       Impact factor: 3.847

Review 6.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

7.  Neurophysiological studies and non-motor symptoms prior to ataxia in a patient with machado-joseph disease: trying to understand the natural history of brain degeneration.

Authors:  José Luiz Pedroso; Edson Bor-Seng-Shu; Pedro Braga-Neto; Rodrigo Souza Ribeiro; Márcio Luiz Escorcio Bezerra; Lucila B F do Prado; Ilza Rosa Batista; Helena Alessi; Manoel Jacobsen Teixeira; Gilberto Mastrocola Manzano; Gilmar Fernandes do Prado; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

8.  Cognitive and Psychiatric Evaluation in SYNE1 Ataxia.

Authors:  Maria Thereza Drumond Gama; Pedro Braga-Neto; Livia Almeida Dutra; Helena Alessi; Lilia Alves Maria; Ary Araripe Gadelha; Bruno Bertolucci Ortiz; Ilda Kunii; Silvia Regina Correia-Silva; Magnus R Dias da Silva; Patrick A Dion; Guy A Rouleau; Marcondes Cavalcante França; Orlando G P Barsottini; José Luiz Pedroso
Journal:  Cerebellum       Date:  2019-08       Impact factor: 3.847

9.  Executive dysfunction in patients with spinocerebellar ataxia type 3.

Authors:  Itaru Tamura; Asako Takei; Shinsuke Hamada; Hiroyuki Soma; Michio Nonaka; Sanae Homma; Fumio Moriwaka
Journal:  J Neurol       Date:  2018-05-03       Impact factor: 4.849

10.  Widespread neuronal damage and cognitive dysfunction in spinocerebellar ataxia type 3.

Authors:  Tátila Martins Lopes; Anelyssa D'Abreu; Marcondes Cavalcante França; Clarissa Lin Yasuda; Luiz Eduardo Betting; Adriana Bastos Samara; Gabriela Castellano; Júlio César Somazz; Marcio Luiz Figueredo Balthazar; Iscia Lopes-Cendes; Fernando Cendes
Journal:  J Neurol       Date:  2013-06-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.